CHINA HEALTH GRP HD-10 (F:VNL1) — Stock Price
CHINA HEALTH GRP HD-10 (F:VNL1) is currently trading at €0.00 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €0.00 and €0.01. This page tracks CHINA HEALTH GRP HD-10's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see CHINA HEALTH GRP HD-10 market cap and net worth.
CHINA HEALTH GRP HD-10 (VNL1) Stock Price Chart — Daily History & Trading Volume
The chart below tracks CHINA HEALTH GRP HD-10's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
CHINA HEALTH GRP HD-10 Income Statement — Revenue, Profit & Earnings by Year
CHINA HEALTH GRP HD-10's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Revenue | €26.45 Million | €21.43 Million | €13.09 Million | €83.60 Million |
| Cost of Revenue | €16.39 Million | €13.21 Million | €7.35 Million | €19.74 Million |
| Gross Profit | €10.07 Million | €8.21 Million | €5.74 Million | €63.86 Million |
| Research & Development | — | — | — | — |
| SG&A | €10.08 Million | €7.61 Million | €13.97 Million | €21.39 Million |
| Total Operating Expenses | €41.30 Million | €79.76 Million | €29.15 Million | €41.51 Million |
| Operating Income | €-14.85 Million | €-58.33 Million | €-16.06 Million | €42.09 Million |
| EBITDA | — | — | — | — |
| EBIT | — | — | — | — |
| Interest Expense | — | €0.00 | €17.00K | €15.00K |
| Income Before Tax | €-14.47 Million | €-58.21 Million | €-15.83 Million | €42.52 Million |
| Income Tax Expense | — | — | — | — |
| Net Income | €0.00 | €-58.01 Million | €-15.83 Million | €36.33 Million |
CHINA HEALTH GRP HD-10 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes CHINA HEALTH GRP HD-10's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Assets | €100.96 Million | €119.35 Million | €178.62 Million | €194.32 Million |
| Total Current Assets | €92.64 Million | €112.18 Million | €177.23 Million | €192.78 Million |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | €1.70 Million | €3.16 Million | €8.01 Million | €5.66 Million |
| Net Receivables | €46.67 Million | €63.61 Million | €108.82 Million | €128.51 Million |
| Inventory | — | — | — | — |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | — | — | — | — |
| Total Liabilities | €31.24 Million | €35.17 Million | €36.74 Million | €38.75 Million |
| Total Current Liabilities | €31.24 Million | €35.17 Million | €36.74 Million | €38.75 Million |
| Long-term Debt | — | — | — | — |
| Net Debt | — | — | — | — |
| Total Stockholder Equity | €70.35 Million | €84.82 Million | €142.32 Million | €155.57 Million |
| Retained Earnings | €-67.51 Million | €-53.33 Million | €4.13 Million | €19.50 Million |
CHINA HEALTH GRP HD-10 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how CHINA HEALTH GRP HD-10 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Operating Cash Flow | €10.28 Million | €1.12 Million | €-5.16 Million | €-10.28 Million |
| Capital Expenditures | €1.76 Million | €6.00 Million | €0.00 | €0.00 |
| Free Cash Flow | €8.52 Million | €-4.88 Million | €-5.16 Million | €-10.28 Million |
| Investing Cash Flow | — | — | — | — |
| Financing Cash Flow | — | — | — | — |
| Dividends Paid | — | — | — | — |
| Stock-Based Compensation | €53.00K | €511.00K | €2.14 Million | €572.00K |
| Depreciation | €606.00K | €234.00K | €151.00K | €201.00K |
| Change in Cash | €10.05 Million | €80.00K | €-7.30 Million | €-4.83 Million |
CHINA HEALTH GRP HD-10 Earnings History — EPS Actual vs. Analyst Estimates
Track CHINA HEALTH GRP HD-10's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Nov 08, 2024 | — | — | — |